EULAV Asset Management

Q2 2020 13F-HR Holdings

Location
New York, NY
Holdings as of
6/30/2020
Date filed
8/11/2020
Form type
13F-HR
Num holdings
254
Total value ($000)
$3,054,443
Net value change ($000)
+554,351 (22.2%)
New positions
7
Sold out positions
6
Turnover %
3.1%
Sector allocation + QoQ delta (equities-only)
Prev filing: 4/27/2020 Next filing: 11/5/2020 SEC filing

Snapshot: Change Analysis

Compared to Q1 2020
Methodology: sector metrics are equities-only; instrument mix chart is ex-options; options exposure is shown separately. Why this matters.
Top Adds (Value $000, Stocks/ETFs)
Biohaven Pharmaceutical Holding Co Ltd. 15,995 127.0%
ACN 12,948 31.5%
CDNS 12,913 45.3%
HEI 12,878 33.6%
ROP 12,822 24.5%
DHR 12,665 27.8%
TDG 12,284 38.1%
CRM 12,268 31.6%
CTAS 12,043 54.4%
NOW 11,967 35.4%
Top Reduces (Value $000, Stocks/ETFs)
AON -9,729 -100.0%
APH -7,499 -100.0%
EW -7,168 -100.0%
TTC -5,637 -16.2%
VRSN -5,313 -100.0%
AME -4,319 -24.0%
TTD -3,281 -100.0%
ZTS -2,976 -42.8%
EL -2,812 -53.4%
INTERCEPT PHARMACEUTICALS, INC. -2,273 -23.9%
Instrument mix + QoQ Δ (ex-options)
How this table is calculated: SEC VALUE ($000) is used as reported. For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received. Column % is bucket-based: non-options share is calculated inside non-option total, options share is calculated inside options total. Details.
Filter:
Instrument:
Issuer Name Ticker Sector Industry Class History Value ($000) % Shares Shares Δ Shares Δ% Value Δ ($000) Value Δ% Principal Option Type